银屑病的新治疗选择。
New treatment options for psoriasis.
作者信息
McClelland P B
机构信息
University of California, San Francisco, USA.
出版信息
Dermatol Nurs. 1997 Oct;9(5):295-304; quiz 305-6.
PMID:9392761
Abstract
Psoriasis is a chronic genetic disease characterized by hyperproliferation and inflammation of the epidermis and dermis. Presently there is no cure for psoriasis, only treatments to alleviate the symptoms. Tazarotene (Tazorac) is a new vitamin A derivative and the first topical retinoid to demonstrate therapeutic success in treating plaque-type psoriasis. This article will introduce you and your patients to the safe and effective use of tazarotene.
摘要
银屑病是一种慢性遗传性疾病，其特征为表皮和真皮的过度增殖与炎症。目前银屑病无法治愈，只有缓解症状的治疗方法。他扎罗汀（Tazorac）是一种新型维生素A衍生物，也是首个在治疗斑块型银屑病方面显示出治疗成效的外用维甲酸类药物。本文将向您及您的患者介绍他扎罗汀的安全有效使用方法。
相似文献
1
New treatment options for psoriasis.
Dermatol Nurs. 1997 Oct;9(5):295-304; quiz 305-6.
2
Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
J Am Acad Dermatol. 1998 May;38(5 Pt 1):705-11. doi: 10.1016/s0190-9622(98)70594-8.
3
Obtaining the optimal treatment outcome with tazarotene.
Dermatol Nurs. 1998 Oct;10(5):343-8.
4
Clinical safety of tazarotene in the treatment of plaque psoriasis.
J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S25-32.
5
Tazarotene gel: efficacy and safety in plaque psoriasis.
J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S33-8.
6
The efficacy of topical tazarotene monotherapy and combination therapies in psoriasis.
Expert Opin Pharmacother. 2003 Dec;4(12):2347-54. doi: 10.1517/14656566.4.12.2347.
7
[Medication of the month. Tazarotene 0.05%-0.1% (Zorac)].
Rev Med Liege. 2003 Nov;58(11):706-8.
8
[Prescribe topical treatments for psoriasis].
Rev Prat. 2004 Jan 15;54(1):40-2.
9
10
Zotero 插件